Is anticoagulation therapy underused in elderly patients with atrial fibrillation?

Drugs and Aging

Volumn 10, Issue 3, 1997, Pages 174-184

  Turazza, Fabio M ^a   Franzosi, Maria G ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SINUS RHYTHM; STROKE; THROMBOEMBOLISM;

EID: 0030905147     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710030-00002     Document Type: Review

References (37)

1. Ostrander Jr LK, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community: Tecumseh, Michigan. Circulation 1965; 31: 888-98
2. Kulbertus HE, Leval-Rutten FD, Bartsch P, et al. Atrial fibrillation in elderly ambulatory patients. In: Kulbertus HE, Olsson SB, Schlepper M, editors. Atrial fibrillation, Kiruna, Sweden. Mölndal: AB Hässle, 1982: 148-57
3. Örndahl G, Thulesius O, Hood B. Incidence of persistent atrial fibrillation and conduction defects in coronary heart disease. Am Heart J 1972; 84: 120-31
4. Godtfredsen J. Atrial fibrillation: etiology, course and prognosis. A follow-up study of 1,212 cases. Copenhagen: Munksgaard, 1975
5. Petersen P, Godtfredsen J. Atrial fibrillation - a review of course and prognosis. Acta Med Scand 1984; 216: 5-9
6. Halpern JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988; 19: 937-41
7. Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996; 44: 521-3
8. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-22
9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med 1987; 147: 1561-4
10. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 1983; 106: 389-96
11. Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7
12. Wolf PA, Kannel WB, McGee DL, et al. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983; 14: 664-7
13. Brand FN, Abbott BD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30 year follow-up in the Framingham study. JAMA 1985; 254: 3445-53
14. Lake FR, McCall MG, Cullen KJ, et al. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989; 19: 321-6
15. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987; 317: 669-74
16. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation, 30 year follow-up in the Framingham study. JAMA 1985; 254: 3449-53
17. Weiner I, Hafner R, Nicolai M, et al. Clinical and echocardiographic correlates of systemic embolisation in non-rheumatic atrial fibrillation. Am J Cardiol 1987; 59: 177-9
18. Takahashi J, Seki A, Imataka K, et al. Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn Heart J 1981; 22: 143-9
19. Shimomur K, Ohe T, Uehara S, et al. Significance of atrial fibrillation as a precursor of embolism. Am J Cardiol 1989; 63: 1405-7
20. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11
21. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Investigators study: final results. Circulation 1991; 84: 527-39
22. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 1994; 343: 687-91
23. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348: 633-8
24. Abbott WM, Maloney RD, McCabe CC, et al. Arterial embolism: a 44 year perspective. Am J Surg 1982; 143: 460-4
25. Aberg H. Atrial fibrillation: I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969; 185: 373-9
26. Hinton RC, Kistler JP, Fallon JT, et al. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977; 40: 509-13
27. Yamanouchi H, Tomonaga M, Shimada H, et al. Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly. Stroke 1989; 20: 1653-6
28. Fisher CM. Reducing risks of cerebral embolism. Geriatrics 1979; 34: 59-66
29. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964; 1: 1209-12
30. Ezekowitz MD, Bridgest SL, James KE, et al. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 1992; 327: 1406-12
31. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet 1989; I: 175-9
32. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991; 18: 349-55
33. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-62
34. Stroke Prevention in Atrial Fibrillation Investigators. A differential effect of aspirin on prevention of stroke in atrial fibrillation. J Stroke Cerebrovasc Dis 1993; 3: 181-8
35. King D, Davies KN, Slee A, et al. Atrial fibrillation in the elderly: physicians' attitudes to anticoagulation, Br J Clin Pract 1995; 49 (3): 123-5
36. McCrory DC, Matchar DB, Samsa G, et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155 (3): 277-81
37. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 1994; 154: 1945-53